A panel of vaccine advisers to the federal government debated several changes to COVID-19 vaccine access in a chaotic meeting Friday, marked by confusion over processes, technical difficulties and passionate disagreement among members and other experts in attendance. Ultimately, the committee backed away from its most controversial proposal that called for states to require those who want a COVID-19 vaccine to get a prescription.